Cargando…
DNA Based Vaccine Expressing SARS-CoV-2 Spike-CD40L Fusion Protein Confers Protection Against Challenge in a Syrian Hamster Model
SARS-CoV-2 infections present a tremendous threat to public health. Safe and efficacious vaccines are the most effective means in preventing the infections. A variety of vaccines have demonstrated excellent efficacy and safety around the globe. Yet, development of alternative forms of vaccines remai...
Autores principales: | Tamming, Levi A., Duque, Diana, Tran, Anh, Zhang, Wanyue, Pfeifle, Annabelle, Laryea, Emmanuel, Wu, Jianguo, Raman, Sathya N. Thulasi, Gravel, Caroline, Russell, Marsha S., Hashem, Anwar M., Alsulaiman, Reem M., Alhabbab, Rowa Y., Gao, Jun, Safronetz, David, Cao, Jingxin, Wang, Lisheng, Chen, Wangxue, Johnston, Michael J. W., Sauve, Simon, Rosu-Myles, Michael, Li, Xuguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789660/ https://www.ncbi.nlm.nih.gov/pubmed/35095861 http://dx.doi.org/10.3389/fimmu.2021.785349 |
Ejemplares similares
-
Single Immunization of a Vaccine Vectored by a Novel Recombinant Vaccinia Virus Affords Effective Protection Against Respiratory Syncytial Virus Infection in Cotton Rats
por: Russell, Marsha S., et al.
Publicado: (2021) -
Bivalent vaccines effectively protect mice against influenza A and respiratory syncytial viruses
por: Raman, Sathya N. Thulasi, et al.
Publicado: (2023) -
DNA lipid nanoparticle vaccine targeting outer surface protein C affords protection against homologous Borrelia burgdorferi needle challenge in mice
por: Pfeifle, Annabelle, et al.
Publicado: (2023) -
Synthetic vaccine affords full protection to mice against lethal challenge of influenza B virus of both genetic lineages
por: Gravel, Caroline, et al.
Publicado: (2021) -
The Expression Kinetics and Immunogenicity of Lipid Nanoparticles Delivering Plasmid DNA and mRNA in Mice
por: Zhang, Wanyue, et al.
Publicado: (2023)